Journey Medical DERM
NASDAQ DERM
$6.61 -0.11 (-1.64%)
At close: Oct 2, 2026 · 4:00 PM EDT

Journey Medical (DERM) Return on Sales [ROS] (2020 - 2026)

Updated

Journey Medical (DERM) posted Return on Sales [ROS] of 2.46% for Q2 2026, up 21.63 percentage points from -19.16% a year earlier and up 11.81 percentage points from the prior quarter.

Analysis

Journey Medical (DERM) Return on Sales [ROS] (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at Journey Medical was -4.41%, up 7.75 percentage points year-over-year; for FY2025, it was -13.21%, up 11.15 percentage points from FY2024.

  • Annual Return on Sales [ROS] shows a five-year change of -30.84 percentage points (FY2020 to FY2025).
  • In prior years, Journey Medical's Return on Sales [ROS] was -24.36% in FY2024 (-21.75 pp), -2.62% in FY2023 (+34.73 pp), -37.35% in FY2022 (+17.90 pp) and -55.25% in FY2021 (-72.88 pp).
  • The Q2 2026 figure stands as the highest quarterly Return on Sales [ROS] since Q4 2024.
  • On a year-over-year basis, Return on Sales [ROS] increased in six of the last eight quarters, with an average year-over-year change of +5.34 percentage points.
  • The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q3 2023, with a gain of 108.83 percentage points; the weakest was Q4 2021, with a drop of 78.13 percentage points.
  • According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -9.35% (Q1 2026), -2.76% (Q4 2025) and -8.67% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Journey Medical 181.73 Mn 79.82 Mn 12.37 Mn 2.46%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.46%
Mar 31, 2026 -9.35%
Dec 31, 2025 -2.76%
Sep 30, 2025 -8.67%
Jun 30, 2025 -19.16%
Mar 31, 2025 -25.30%
Dec 31, 2024 16.40%
Sep 30, 2024 -19.78%
Jun 30, 2024 -19.70%
Mar 31, 2024 -77.44%
Dec 31, 2023 -13.79%
Sep 30, 2023 49.93%
Jun 30, 2023 -44.57%
Mar 31, 2023 -78.29%
Dec 31, 2022 -62.60%
Sep 30, 2022 -58.90%
Jun 30, 2022 -39.05%
Mar 31, 2022 -3.81%
Dec 31, 2021 -51.70%
Sep 30, 2021 -64.49%
API Access

Journey Medical Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=DERM&period=max&api_key=YOUR_API_KEY